Beta-Glucanase Market

Beta-Glucanase Market Size, Market Forecast and Outlook By FMI

In 2025, the Beta-Glucanase market was valued at USD 438.1 million. Based on Future Market Insights' analysis, demand for Beta-Glucanase is estimated to grow to USD 495.0 million in 2026 and USD 912.0 million by 2036. FMI projects a CAGR of 6.3% during the forecast period.

The absolute dollar expansion from 2026 to 2036 amounts to approximately USD 417.0 million, reflecting strong demand pull from dietary supplement manufacturers and functional food formulators seeking evidence-backed immune and cardiovascular health ingredients. Growth is moderated by the premium cost of certified and standardized Beta-Glucanase preparations relative to competing immunomodulatory ingredients, and by the complexity of clinical substantiation required for certain health claim pathways under FDA and EFSA regulatory frameworks.

As per FMI, growing consumer awareness of immune health and cardiovascular risk management, combined with regulatory-approved health claims for beta-glucan-containing products in key markets, creates a durable demand foundation for Beta-Glucanase across functional food and nutraceutical manufacturing supply chains. China leads country-level growth at 8.5% CAGR, driven by domestic nutraceutical market expansion, active government investment in enzyme biotechnology research, and Angel Yeast's commercial-scale production of yeast-derived Beta-Glucanase for export and domestic food applications. India follows at 7.9%, with demand anchored in Ayurveda-adjacent functional supplement formulation and growing institutional procurement from pharmaceutical-grade supplement manufacturers.

Summary of Beta-Glucanase Market

• Beta-Glucanase Market Definition
  • The Beta-Glucanase Market is estimated to be valued at USD 495.0 million in 2026 and is projected to reachUSD 912.0 million by 2026, registering a compound annual growth rate (CAGR) of 6.3% over the forecast period. Leading Segment in Beta-Glucanase Market in 2026: Yeast (47.3%) Key Growth Regions in Beta-Glucanase Market: North America, Asia-Pacific, Europe Top Key Players in Beta-Glucanase Market: Cargill Inc (USA), Kerry Group Plc (Ireland), AIT Ingredients (France), Ohly GmbH (Germany), Biorigin Zilor (Brazil), Alltech Life Sciences (USA), Tate & Lyle Plc (UK), Koninklijke DSM N.V.
• Demand Drivers in the Market
  • Rising demand for beta-glucanase across food processing and industrial applications accelerates procurement volumes among large-scale manufacturers targeting cost efficiency.
  • Expanding yeast adoption within China and adjacent high-growth economies drives volume commitments that justify dedicated supply chain investments.
  • Regulatory and sustainability mandates compel formulation teams to source certified beta-glucanase inputs, shifting purchasing decisions toward verified, compliant suppliers.
• Key Segments Analyzed in the FMI Report
  • Yeast: 47.3% share in 2026, representing the dominant category as buyers prioritize established yeast configurations that align with existing processing and formulation infrastructure.
  • Soluble Beta-Glucanase: 61.8% share in 2026, driven by end-use applications where soluble beta-glucanase characteristics deliver measurable performance advantages over alternative product forms.
  • China: 8.5% compound growth anchored by expanding manufacturing capacity and government-supported industrial development programs targeting beta-glucanase production and processing.
• Analyst Opinion at FMI
  • Nandini Roy Choudhury, Principal Consultant for Food & Beverage, opines: 'In my analysis of the Beta-Glucanase Market, I observe that the central procurement challenge is not product availability but supplier qualification and traceability. Buyers consolidating volumes around yeast face concentration risk when Tier-1 suppliers cannot demonstrate regulatory compliance documentation at scale. China and comparable high-growth markets at 8.5% CAGR signal structural demand expansion, yet the absence of standardized procurement frameworks creates margin compression for distributors operating without certified channel agreements. Executives who delay formalizing supplier diversification strategies will find their cost structures exposed once regulatory enforcement cycles intensify across major importing economies.'
• Strategic Implications / Executive Takeaways
  • Suppliers must establish verified certification pathways for beta-glucanase to qualify for procurement tenders issued by large food, health, and industrial buyers.
  • Investment priorities should target capacity expansion in high-CAGR geographies to capture incremental demand before supply concentration shifts pricing power.
  • Product development teams should align beta-glucanase formulations with evolving regulatory thresholds in the European Union, United States, and Asia Pacific to maintain market access.
• Methodology
  • Primary Research: FMI conducted detailed technical interviews with procurement directors, formulation specialists, and supply chain engineers across 40 countries to validate adoption timelines and demand assumptions.
  • Desk Research: Analysts aggregated public regulatory filings, trade association publications, government statistical releases, and company annual reports to establish verifiable baseline data.
  • Market-Sizing and Forecasting: Forecasting models apply a bottom-up methodology starting with verified production capacity and consumption volume data, applying region-specific growth assumptions to project adoption trajectories.
  • Data Validation and Update Cycle: Segment forecasts undergo cross-validation against publicly reported revenue volumes from leading industry participants and are updated on a rolling quarterly basis.

Germany records 7.2% CAGR under EFSA-approved health claim frameworks for beta-glucan and oat-fiber cholesterol reduction positioning, supporting premium ingredient procurement by bakery and supplement manufacturers. France advances at 6.6%, driven by fortified dairy and functional beverage formulation activity. The United Kingdom grows at 6.0%, with oat-based soluble Beta-Glucanase commanding sustained demand in heart-health product lines across pharmacy and health food retail. The United States expands at 5.4%, anchored by Cargill, Alltech, and Garuda International supplying standardized yeast Beta-Glucanase to dietary supplement contract manufacturers. Brazil posts 4.7%, with early-stage functional food adoption and animal feed inclusion as the primary growth driver. For detailed regional intelligence, refer to FMI's Beta-Glucanase Market report.

Beta-Glucanase Market Key Takeaways

Metric	Details
Industry Size (2026)	USD 495.0 million
Industry Value (2036)	USD 912.0 million
CAGR (2026 to 2036)	6.3%

Beta-Glucanase Market Definition

Beta-Glucanase is a polysaccharide compound derived primarily from yeast cell walls, cereal grains (barley and oats), and fungal sources (mushrooms), available in soluble and insoluble functional forms. It is commercially supplied as a bioactive ingredient for immune modulation, cholesterol management, digestive health support, and texture enhancement across dietary supplements, food, beverage, and animal feed applications.

Beta-Glucanase Market Inclusions

The report covers global and regional market sizes for Beta-Glucanase across all commercial source types, functional forms, and application segments, forecast data from 2026 to 2036, and country-level CAGR analysis across more than 40 countries.

Beta-Glucanase Market Exclusions

The scope excludes beta-glucanase enzymes used solely in industrial bioprocessing contexts unrelated to food or health applications, synthetic immune modulators, and finished consumer products in which Beta-Glucanase appears as a listed but non-primary active ingredient below functional threshold levels.

Beta-Glucanase Market Research Methodology

• Primary Research: Analysts conducted structured interviews with procurement specialists, formulation technologists, and regulatory affairs professionals across key producing and consuming countries to validate adoption timelines and commercial driver assessments.
• Desk Research: Data aggregation covered trade body publications, government statistical releases, multilateral agency reports, peer-reviewed research, and primary company disclosures relevant to the Beta-Glucanase market.
• Market-Sizing and Forecasting: Baseline values derive from a bottom-up aggregation model applying region-specific adoption curves and segment penetration rates, cross-referenced against observable trade and production benchmarks from primary and public sources.
• Data Validation and Update Cycle: Segment forecasts are cross-validated against publicly reported financial results from leading market participants and reviewed on a rolling 12-month basis to incorporate material regulatory or commercial developments.

Why is the Beta-Glucanase Market Growing?

The beta-glucanase market is demonstrating steady growth, supported by the rising demand for functional ingredients in food, beverage, feed, and nutraceutical industries. Increasing awareness of digestive health and immunity-boosting products is driving the integration of beta-glucanase into dietary supplements and wellness products. The enzyme’s ability to break down complex beta-glucans into simpler, bioavailable components is being leveraged to improve nutrient absorption and functional efficacy across a wide range of applications.

Growing investments in enzyme biotechnology, along with advancements in fermentation processes, are enhancing product efficiency, stability, and cost-effectiveness. The market is also benefiting from the expansion of clean-label and natural product categories, where beta-glucanase is being increasingly adopted as a natural processing aid.

Regulatory support for safe and effective enzyme-based ingredients in human and animal nutrition is further accelerating adoption As consumer preferences shift toward health-oriented food products and sustainable feed solutions, the market is anticipated to expand significantly, supported by innovation in enzyme formulations and broader acceptance of enzyme-based functional solutions across global markets.

Segmental Analysis

The beta-glucanase market is segmented by source, functionality, application, and geographic regions. By source, beta-glucanase market is divided into Yeast, Cereal (Barley, Oats), and Others (Mushrooms). In terms of functionality, beta-glucanase market is classified into Soluble Beta-Glucanase and Insoluble Beta-Glucanase. Based on application, beta-glucanase market is segmented into Health & Dietary Supplements, Bakery Products, Foods & Beverages, Cosmetics & Personal Care, Dairy & Frozen Products, and Others (Animal Feed). Regionally, the beta-glucanase industry is classified into North America, Latin America, Western Europe, Eastern Europe, Balkan & Baltic Countries, Russia & Belarus, Central Asia, East Asia, South Asia & Pacific, and the Middle East & Africa.

Insights into the Yeast Source Segment

The yeast source segment is projected to account for 47.3% of the beta-glucanase market revenue share in 2025, making it the leading source category. This dominance is being attributed to the abundance of yeast-derived beta-glucans in various applications and the cost-effective production methods associated with yeast fermentation. The enzymatic extraction from yeast provides high yield and consistency, which supports large-scale commercial use in both food and feed industries.

The stability and effectiveness of yeast-derived beta-glucanase have been demonstrated across a wide range of processing environments, making it suitable for industrial applications that require reliable enzyme activity under varying conditions. The demand for yeast-based solutions is also being reinforced by their acceptance in natural and clean-label formulations, aligning with growing consumer interest in sustainable and traceable sources.

Advances in fermentation technologies and strain development are enabling higher enzyme purity and activity, ensuring consistent performance across applications As industries prioritize efficiency and sustainability, yeast remains the most practical and scalable source of beta-glucanase, solidifying its leadership position in the global market.

Insights into the Soluble Beta-Glucanase Functionality Segment

The soluble beta-glucanase functionality segment is expected to hold 61.8% of the beta-glucanase market revenue share in 2025, establishing it as the leading functionality type. Its growth is being driven by the superior solubility and ease of incorporation into liquid and powdered formulations, making it highly suitable for nutraceuticals, beverages, and functional foods. Soluble beta-glucanase enhances bioavailability and efficacy, supporting its adoption in products targeted toward improving digestion and immune function.

The ability of soluble forms to retain stability across a range of processing conditions is further increasing their application potential in health and dietary supplements. Manufacturers are prioritizing soluble formulations due to their ability to blend seamlessly with other ingredients without compromising texture or taste, which is critical in consumer-facing products.

The segment’s expansion is also linked to ongoing research in biotechnology aimed at optimizing solubility and enzymatic activity With the growing trend toward functional and fortified food solutions, soluble beta-glucanase is expected to remain the preferred choice for manufacturers, ensuring its strong contribution to overall market growth.

Insights into the Health and Dietary Supplements Application Segment

The health and dietary supplements application segment is anticipated to capture 29.3% of the beta-glucanase market revenue share in 2025, making it the dominant application. The leadership of this segment is being fueled by the increasing consumer focus on digestive wellness, immunity enhancement, and preventive healthcare. Beta-glucanase is being incorporated into dietary supplements to improve the breakdown of beta-glucans, thereby enhancing nutrient absorption and overall effectiveness of formulations.

Its role in supporting gut health and immunity is particularly relevant as consumers prioritize natural solutions to strengthen resilience against lifestyle-related disorders and infections. The expanding nutraceutical sector, combined with rising disposable incomes and health-conscious lifestyles, is reinforcing demand for enzyme-based supplements. Regulatory acceptance of beta-glucanase as a safe and beneficial dietary ingredient is further driving adoption in supplement formulations.

The ability to combine beta-glucanase with other functional ingredients in capsules, powders, and liquid supplements is increasing product diversity and accessibility As the global demand for wellness products accelerates, the health and dietary supplements segment is expected to remain the largest contributor to market revenues.

Market Overview

Beta-Glucanase Market Outlook (2026 to 2036)

A novel substance called beta-glucanase is currently being introduced to the market. It is a nutritional supplement produced from yeast cell walls. According to some research, beta-glucanase is good for the heart and can lower the chance of developing heart disease. Clinical testing of the product has shown that it effectively lowers levels of harmful cholesterol.

Beta-Glucanase Market Drivers, Restraints, and Opportunities

Future Market Insights analysis of the Beta-Glucanase market shows that demand is structured around specific procurement requirements across industrial, retail, and regulated product categories. FMI analysts observe that growth performance varies across application and regional segments, with premium and specialty demand tiers delivering above-average revenue per unit relative to standard commodity-grade supply.

FMI is of the opinion that the structural dynamic in this market reflects the interplay between production cost constraints and downstream buyer quality certification requirements. Suppliers able to demonstrate supply chain traceability, batch consistency, and regulatory compliance are positioned to secure disproportionate share of the premium procurement tier across all major geographic markets.

• EFSA and FDA-Recognized Heart Health Claims: The European Food Safety Authority (EFSA) has recognized that beta-glucan from oats and barley contributes to the maintenance of normal blood cholesterol levels, enabling food manufacturers in EU markets to carry qualified health claims on products containing minimum daily dose thresholds. This regulatory pathway has created a high-value procurement demand from Tate and Lyle and Kerry Group for certified soluble Beta-Glucanase ingredients that meet purity and beta-glucan concentration specifications required for claim substantiation.
• Immune Health Supplement Demand: Post-pandemic consumer prioritization of immune health supplementation has sustained above-average category growth in yeast-derived Beta-Glucanase ingredients positioned for immune modulation applications. Alltech Life Sciences and Biotec BetaGlucans AS supply pharmaceutical-grade yeast Beta-Glucanase to contract manufacturers formulating capsule, tablet, and powder supplement products marketed for immune resilience, with demand concentrated in North America, Western Europe, and expanding across East and South Asian supplement markets.
• Bakery and Cereal Fiber Fortification: Functional bakery manufacturers in Western Europe and North America are incorporating soluble Beta-Glucanase from oat and barley sources to meet consumer demand for fiber-enriched bread, breakfast cereals, and health bars carrying front-of-pack fiber and heart-health messaging. Koninklijke DSM and AIT Ingredients supply standardized cereal-derived Beta-Glucanase preparations that meet HACCP and EU organic certification requirements, enabling bakery producers to combine technical functionality with clean-label ingredient positioning.

Analysis of Beta-Glucanase Market By Key Countries

Country	CAGR
China	8.5%
India	7.9%
Germany	7.2%
France	6.6%
UK	6.0%
USA	5.4%
Brazil	4.7%

Country-wise Analysis

The Beta-Glucanase Market is expected to register a CAGR of 6.3% during the forecast period, exhibiting varied country level momentum. China leads with the highest CAGR of 8.5%, followed by India at 7.9%. Developed markets such as Germany, France, and the UK continue to expand steadily, while the USA is likely to grow at consistent rates. Brazil posts the lowest CAGR at 4.7%, yet still underscores a broadly positive trajectory for the global Beta-Glucanase Market. In 2024, Germany held a dominant revenue in the Western Europe market and is expected to grow with a CAGR of 7.2%. The USA Beta-Glucanase Market is estimated to be valued at USD 174.1 million in 2025 and is anticipated to reach a valuation of USD 293.3 million by 2035. Sales are projected to rise at a CAGR of 5.4% over the forecast period between 2025 and 2035. While Japan and South Korea markets are estimated to be valued at USD 22.5 million and USD 16.2 million respectively in 2025.

Key Players in the Beta-Glucanase Market

• Cargill Inc (USA)
• Kerry Group Plc (Ireland)
• AIT Ingredients (France)
• Ohly GmbH (Germany)
• Biorigin Zilor (Brazil)
• Alltech Life Sciences (USA)
• Tate & Lyle Plc (UK)
• Koninklijke DSM N.V. (Netherlands)
• Garuda International Inc (USA)
• Angel Yeast Co Ltd (China)
• Biotec BetaGlucans AS (Norway)
• Ceapro Inc (Canada)

Scope of the Report

Metric	Value
Quantitative Units	USD 495.0 million to USD 912.0 million, at a CAGR of 6.3%
Market Definition	Beta-Glucanase is a polysaccharide compound derived primarily from yeast cell walls, cereal grains (barley and oats), and fungal sources (mushrooms), available in soluble and insoluble functional forms. It is commercially supplied as a bioactive ingredient for immune modulation, cholesterol management, digestive health support, and texture enhancement across dietary supplements, food, beverage, and animal feed applications.
Source Segmentation	Yeast, Cereal (Barley and Oats), Others (Mushrooms)
Functionality Segmentation	Soluble Beta-Glucanase, Insoluble Beta-Glucanase
Application Segmentation	Health and Dietary Supplements, Bakery Products, Foods and Beverages, Cosmetics and Personal Care, Dairy and Frozen Products, Others (Animal Feed)
Regions Covered	North America, Latin America, Western Europe, Eastern Europe, East Asia, South Asia and Pacific, Middle East and Africa
Countries Covered	United States, Canada, Germany, France, United Kingdom, China, Japan, India, Brazil, South Africa, and 40 plus countries
Forecast Period	2026 to 2036
Key Companies Profiled	Cargill Inc. (USA), Kerry Group Plc (Ireland), AIT Ingredients (France), Ohly GmbH (Germany), Biorigin Zilor (Brazil), Alltech Life Sciences (USA), Tate and Lyle Plc (UK), Koninklijke DSM N.V. (Netherlands), Garuda International Inc. (USA), Angel Yeast Co. Ltd. (China), Biotec BetaGlucans AS (Norway), Ceapro Inc. (Canada)
Approach	Hybrid bottom-up and top-down forecasting model, cross-validated against primary interview findings and public benchmark data

Beta-Glucanase Market by Segments

Source:

• Yeast
• Cereal (Barley, Oats)
• Others (Mushrooms)

Functionality:

• Soluble Beta-Glucanase
• Insoluble Beta-Glucanase

Application:

• Health & Dietary Supplements
• Bakery Products
• Foods & Beverages
• Cosmetics & Personal Care
• Dairy & Frozen Products
• Others (Animal Feed)

Region:

• North America
  • USA
  • Canada
  • Mexico
• Latin America
  • Brazil
  • Chile
  • Rest of Latin America
• Western Europe
  • Germany
  • UK
  • Italy
  • Spain
  • France
  • Nordic
  • BENELUX
  • Rest of Western Europe
• Eastern Europe
  • Russia
  • Poland
  • Hungary
  • Balkan & Baltic
  • Rest of Eastern Europe
• East Asia
  • China
  • Japan
  • South Korea
• South Asia and Pacific
  • India
  • ASEAN
  • Australia & New Zealand
  • Rest of South Asia and Pacific
• Middle East & Africa
  • Kingdom of Saudi Arabia
  • Other GCC Countries
  • Turkiye
  • South Africa
  • Other African Union
  • Rest of Middle East & Africa

Bibliography

• 1. European Food Safety Authority (EFSA). (2024, January). Scientific opinion: Beta-glucans and maintenance of normal blood cholesterol concentrations. EFSA Journal.
• 2. United States Food and Drug Administration (FDA). (2024, March). Health claim notification: Soluble dietary fiber from oat products and coronary heart disease. FDA.
• 3. World Health Organization (WHO). (2023, November). Cardiovascular disease prevention: Dietary fiber and cholesterol guidance. WHO. 
• 4. European Commission, Directorate-General for Health and Food Safety. (2024, February). EU register of authorized health claims under Regulation (EC) No 1924/2006. European Commission.
• 5. India Ministry of Ayurveda, Yoga and Naturopathy, Unani, Siddha and Homeopathy (AYUSH). (2024, April). Annual report 2023-24: Traditional medicine and nutraceutical sector. Government of India.
• 6. China National Health Commission. (2024, March). National nutrition plan 2024: Functional food and dietary supplement policy guidance. Government of China.

This Report Addresses

• Market sizing and quantitative forecast metrics detailing the precise enterprise software expenditure dedicated to packaging void-fill reduction across major retail sectors through 2036.
• Segmentation analysis mapping the adoption velocity of specific cartonization algorithms and evaluating the technical limitations driving cloud platform migrations.
• Regional deployment intelligence comparing the aggressive greenfield fulfillment strategies in Asia Pacific against the complex brownfield software integration requirements prevalent in European logistics hubs.
• Regulatory compliance assessment analyzing how stringent secondary packaging waste directives and Extended Producer Responsibility mandates force the adoption of precision volumetric software.
• Competitive posture evaluation tracking the mandatory shift toward hardware-agnostic API integration and the resulting commoditization of standalone dimensional calculators.
• Capital project strategic guidance defining the exact procurement specifications and processing latencies required to support next-generation automated right-sizing machinery.
• Supply chain vulnerability analysis identifying the specific data synchronization bottlenecks that extend warehouse execution system commissioning timelines.
• Custom data delivery formats encompassing interactive dashboards, raw Excel datasets, and comprehensive PDF narrative reports.